IXAZOMIB CITRATE CAS No.1239908-20-3 Pharmaceutical Intermediates

Introducing IXAZOMIB CITRATE, a potent oral proteasome inhibitor specifically developed for the treatment of multiple myeloma and other hematological malignancies. Our products are characterized by high purity, stability and efficacy, making them an essential component of modern cancer treatment. As a factory integrating production and trading, we ensure competitive prices, strict quality control and reliable supply chain. Choose us as your trusted partner in drug innovation and enhance your product offerings with IXAZOMIB CITRATE.

product details

Product details

Product detail

IXAZOMIB CITRATE is an innovative compound that belongs to the class of proteasome inhibitors, which play a key role in regulating protein degradation within cells. By inhibiting the proteasome, IXAZOMIB CITRATE impairs the degradation of pro-apoptotic factors, leading to the accumulation of these proteins and ultimately inducing apoptosis in cancer cells. This mechanism of action makes IXAZOMIB CITRATE a valuable treatment option for patients with relapsed or refractory multiple myeloma, especially when used in combination with other drugs.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Physical and Chemical Properties

The molecular formula of IXAZOMIB CITRATE isC20H23BCl2N2O9, and the molecular weight of the active ingredient is about 517.12g/mol, with the citrate salt accounting for its total weight. The compound is a white powder and is stable under standard storage conditions. It is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, but has limited solubility in water.

The melting point of IXAZOMIB CITRATE is typically between 150°C and 155°C, ensuring its stability during handling and storage. Its good solubility and stability properties make it suitable for oral administration, which can facilitate the formulation of dosing regimens and improve patient compliance.

Advantages

1. Cancer treatment efficacy: IXAZOMIB CITRATE has demonstrated significant efficacy in multiple myeloma patients in clinical trials, especially when used in combination with other drugs such as lenalidomide and dexamethasone. Its ability to target the proteasome pathway provides a new approach to cancer treatment, bringing hope to patients with limited treatment options.

2. Oral bioavailability: One of the main advantages of IXAZOMIB CITRATE is its oral bioavailability, which makes administration more convenient compared to traditional intravenous therapy. This feature not only improves patient compliance, but also reduces the burden on medical institutions, making it a practical option for outpatient treatment.

3. High Purity and Quality Assurance: As a manufacturer integrating production and trading, we prioritize quality control throughout the entire production process. Our IXAZOMIB CITRATE is produced under strict guidelines, ensuring high purity levels that meet or exceed industry standards. This commitment to quality is essential for pharmaceutical companies seeking reliable and effective formulation ingredients.

4. Competitive Pricing: By optimizing our production processes and leveraging our manufacturing capabilities, we are able to offer IXAZOMIB CITRATE at a competitive price. This affordable price makes it an attractive option for pharmaceutical companies looking to enhance their product portfolio without compromising on quality.

5. Reliable supply chain management: We adopt an integrated production and trading approach to ensure a reliable supply chain, enabling us to meet customer needs in a timely manner. We understand the importance of timely delivery in the pharmaceutical industry and are committed to providing consistent and reliable services to our partners.

In summary

In summary, IXAZOMIB CITRATE represents a significant advancement in the treatment of multiple myeloma and other hematologic malignancies. Its unique physical and chemical properties, combined with its proven efficacy and our commitment to quality, make it an ideal choice for pharmaceutical companies seeking innovative solutions. Partner with us to explore the potential of IXAZOMIB CITRATE and take your pharmaceutical products to new heights. Together, we can make a meaningful impact in the fight against cancer and improve patient outcomes.